184 related articles for article (PubMed ID: 10897813)
21. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
[TBL] [Abstract][Full Text] [Related]
22. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
23. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
Aapro MS; Bohlius J; Cameron DA; Dal Lago L; Donnelly JP; Kearney N; Lyman GH; Pettengell R; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
Eur J Cancer; 2011 Jan; 47(1):8-32. PubMed ID: 21095116
[TBL] [Abstract][Full Text] [Related]
24. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
[TBL] [Abstract][Full Text] [Related]
25. [Usefulness of G-CSF in pediatric high risk cancer patients with fever and neutropenia].
Rodríguez Z N; Tordecilla C J; Campbell B M; Joannon S P; Rizzardini L C; Soto A V; Verdugo L P
Rev Chilena Infectol; 2005 Sep; 22(3):223-7. PubMed ID: 16077888
[TBL] [Abstract][Full Text] [Related]
26. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Michel G; Landman-Parker J; Auclerc MF; Mathey C; Leblanc T; Legall E; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Auvrignon A; Berthou C; Bauduer F; Pautard B; Schneider P; Schaison G; Leverger G; Baruchel A
J Clin Oncol; 2000 Apr; 18(7):1517-24. PubMed ID: 10735900
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human granulocyte-macrophage colony-stimulating factor in septic neutropenic pediatric cancer patients: detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery.
Fink FM; Maurer-Dengg K; Fritsch G; Mann G; Zoubek A; Falk M; Gadner H
Med Pediatr Oncol; 1995 Nov; 25(5):365-71. PubMed ID: 7545780
[TBL] [Abstract][Full Text] [Related]
28. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.
Goa KL; Bryson HM
Pharmacoeconomics; 1994 Jan; 5(1):56-77. PubMed ID: 10146867
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel.
Gilad J; Riesenberg K; Mermershtain W; Borer A; Porath A; Schlaeffer F
Support Care Cancer; 1999 Jul; 7(4):260-4. PubMed ID: 10423052
[TBL] [Abstract][Full Text] [Related]
30. The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia.
Haim N; Shulman K; Goldberg H; Tsalic M
Med Oncol; 2005; 22(3):229-32. PubMed ID: 16110133
[TBL] [Abstract][Full Text] [Related]
31. Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.
Marina NM; Shema SJ; Bowman LC; Rodman J; Douglass EC; Furman WL; Pappo A; Santana VM; Hudson M; Meyer WH
Med Pediatr Oncol; 1994; 23(4):328-34. PubMed ID: 8058003
[TBL] [Abstract][Full Text] [Related]
32. [G-CSF and GM-CSF in treatment of neutropaenia after chemotherapy in children with neoplasms].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubala H; Drabko K; Eliasinska A; Kedziora M; Sońta-Jakimczyk D; Sopylo B; Kołecki P; Kowalczyk J; Matysiak M; Rokicka-Milewska R; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M; Płoszyńska A
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):121-9. PubMed ID: 12021471
[TBL] [Abstract][Full Text] [Related]
33. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
Ho P; Sherman P; Grigg A
Eur J Haematol; 2012 May; 88(5):416-21. PubMed ID: 22296221
[TBL] [Abstract][Full Text] [Related]
34. Granulocytic growth factors and cancer-related neutropenia: limited effects.
Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
[TBL] [Abstract][Full Text] [Related]
35. Comparative effect of 100 versus 250 micrograms/m2/day of G-CSF in pediatric patients with neutropenia induced by chemotherapy.
Kubota M; Akiyama Y; Mikawa H; Tsutsui T
Pediatr Hematol Oncol; 1995; 12(4):393-7. PubMed ID: 7577392
[TBL] [Abstract][Full Text] [Related]
36. Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
Barnes G; Pathak A; Schwartzberg L
Adv Ther; 2014 Jul; 31(7):683-95. PubMed ID: 24989316
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human granulocyte-macrophage colony-stimulating factor in children with chemotherapy-induced neutropenia.
Saarinen UM; Hovi L; Riikonen P; Pihkala J; Juvonen E
Med Pediatr Oncol; 1992; 20(6):489-96. PubMed ID: 1435519
[TBL] [Abstract][Full Text] [Related]
38. Shortened time to recovery from chemotherapy induced neutropenia in pediatric patients with high dose combined cytokines.
Deb G; Donfrancesco A; Sio LD; Cozza R; Castellano A; Paole F; Helson L
Anticancer Res; 1998; 18(1B):489-92. PubMed ID: 9568167
[TBL] [Abstract][Full Text] [Related]
39. Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia.
Delorme J; Badin S; Le Corroller AG; Auvrignon AA; Auclerc MF; Gandemer V; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Berthou C; Bauduer F; Pautard B; Vannier JP; Braguer D; Leblanc T; Leverger G; Baruchel A; Michel G
J Pediatr Hematol Oncol; 2003 Jun; 25(6):441-7. PubMed ID: 12794521
[TBL] [Abstract][Full Text] [Related]
40. Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.
Milano-Bausset E; Gaudart J; Rome A; Coze C; Gentet JC; Padovani L; Lacarelle B; André N
Clin Ther; 2009; 31 Pt 2():2388-95. PubMed ID: 20110048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
